tm
Seeing Is Believing
tm
Seeing Is Believing
LFCR is currently covered by 3 analysts with an average price target of $10.41. This is a potential upside of $2.13 (25.72%) from yesterday's end of day stock price of $8.28.
Lifecore Biomedical's activity chart (see below) currently has 8 price targets and 11 ratings on display. The stock rating distribution of LFCR is 42.86% BUY and 57.14% HOLD.
Analysts average stock forecasts to be materialized ratio is 60% with an average time for these price targets to be met of 102 days.
Highest price target for LFCR is $8, Lowest price target is $4.
Most recent stock forecast was given by MICHAEL PETUSKY from BARRINGTON on 28-Aug-2024. First documented stock forecast 11-Jan-2023.
Currently out of the existing stock ratings of LFCR, 3 are a BUY (42.86%), 4 are a HOLD (57.14%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$10
9 months 28 days ago
(28-Aug-2024)
3/5 (60%)
$2.13 (27.06%)
102
What is LFCR (Lifecore Biomedical) average time for price targets to be met?
Which analyst has the current highest performing score on LFCR (Lifecore Biomedical) with a proven track record?
Which analyst has the most public recommendations on LFCR (Lifecore Biomedical)?
Which analyst is the currently most bullish on LFCR (Lifecore Biomedical)?
